Epstein-Barr virus specific salivary antibodies as related to stress caused by examinations

Journal of Medical Virology

Volumn 64, Issue 2, 2001, Pages 149-156

  Carballal, Guadalupe ^a   Videla, Cristina M ^a   Alejandra Espinosa, M ^a   Savy, Vilma ^b   Uez, Osvaldo ^b   Sequeira, Mara D ^c   Knez, Violeta ^a,d   Requeijo, Paula V ^e   Posse, Clara Riva ^f   Miceli, Isabel ^f  

^a CEMIC   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c Ministerio de Salud de la provincia de Buenos Aires   (Argentina)

^d Instituto Nacional de Enfermedades Respiratorias E Coni   (Argentina)

^e FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^f Direccin de Epidemiologa   (Argentina)

Author keywords

Academic stress; Epstein Barr virus; Health status; Hepatitis A virus; IgG and IgA salivary antibodies; Menstrual cycle

Indexed keywords

ANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY PRODUCTION; ARTICLE; CANCER PATIENT; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PREVALENCE; SALIVA LEVEL; SEQUENTIAL ANALYSIS; STRESS; VIRUS ACTIVATION; VIRUS CARRIER; VIRUS REACTIVATION;

ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MENSTRUAL CYCLE; SALIVA; STRESS, PSYCHOLOGICAL; STUDENTS, MEDICAL; VIRUS ACTIVATION;

HEPATITIS A VIRUS; HUMAN HERPESVIRUS 4;

EID: 0035042279     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.1030     Document Type: Article

References (47)

1. Gender and health on the kibbutz
2. Clinical research strategies in psychoneuroimmunology: A review of 46 human research studies
3. Salivary diagnosis of measles: A study of notified cases in the United Kingdom, 1991-1993
4. Psychoneuroimmunology of stress
5. HCV antibodies in saliva and urine
6. Virus specific secretory IgA antibodies as a means of rapid diagnosis of measles and mumps infection
7. Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns
8. Stress-related immunosuppression: Health implication
9. Stress related activation of EBV
10. The differential impact of training stress and final examination stress on herpesvirus latency at the United States Military Academy at West Point
11. Detection of multiple Epstein-Barr virus strains in allogenic bone marrow transplant recipients
12. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B cell lymphoproliferative disease occuring after renal transplantation: Clinical pathologic and virologic findings and implications for therapy
13. Epstein Barr virus infections and DNA hybridizations studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection
14. The frequency of Epstein Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children
15. Prevalence of viral antibodies in gingival crevicular fluid
16. Antibodies to cytomegalo and Epstein Barr viruses in human saliva and gingival fluid
17. Coincidence of Epstein Barr virus reactivation, cytomegalovirus infection and rejection episodes in renal transplant recipients
18. Candida albicans: Cellular immune system interactions during different stages of the menstrual cycle
19. Psychosocial influence on herpesvirus latency
20. Stress and immune function in humans
21. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neuroormones
22. Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus infected cells
23. Serum IgG and IgA antibodies specific to Epstein Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men
24. Sympathetic reactivity to acute stress and immune response in women
25. Chronic stress, leukocyte subpopulations, and humoral response to latent viruses
26. Saliva as a manifestation of the common mucosal immune system
27. Epstein Barr virus infection and its role in the expanding spectrum of human diseases
28. Incidence of Epstein-Barr virus in astronauts saliva during spaceflight
29. Diagnosis of hepatitis A,B and C using oral samples
30. Pathogenesis of Epstein-Barr virus and its associated malignancies
31. Epstein-Barr virus associated syndromes in immunosuppressed liver transplant recipients: Clinical profile and recognition on routine allograft biopsy
32. Epstein-Barr virus
33. Predominance of HCV Type 2a in saliva from intravenous drug users
34. The use of saliva for the detection of IgG antibodies against rubella virus: Comparison of indirect ELISA and antibody capture immunoassay
35. Secretory immunity in HIV infection
36. The use of oral fluid for hepatitis C antibody screening
37. Epstein-Barr virus specific antibodies in Epstein-Barr virus positive and negative gastric carcinoma cases in Japan
38. Epstein Barr virus replication in oropharyngeal epithelial cells
39. Adrenal steroids type I and type II receptor binding: Estimates of in vivo receptor number, occupancy and activation with varying levels of steroids
40. New concepts in ovarian regulation: An immune insight
41. Epstein-Barr virus latent infection in vivo
42. Epstein-Barr virus infections: Biology, pathogenesis and management
43. Detection of rubella virus specific immunoglobin G in saliva by an amplification based enzyme linked immunoabsorbent assay using monoclonal antibody to fluorescein isothiocyanate
44. Detection of HIV Gag p24 specific antibodies in sera and saliva of HIV-1 infected adults and in sera of infants born to HIV-1 infected mothers
45. Comparison of serum and salivary antibodies in children vaccinated with oral live or parenteral inactivated poliovirus vaccines of different antigen concentrations